Section 232 Tariffs on Medical Devices Harm Precision Industry

The Trump administration's Section 232 tariffs on medical devices are criticized as a blunt instrument that threatens a precision industry vital to American healthcare. While the goal of reducing dependence on foreign adversaries is clear, these tariffs risk increasing costs for patients and disrupting supply chains without guaranteeing domestic production. The policy highlights the tension between economic nationalism and the specialized needs of the medical technology sector.